Looks like we have some green action premarket with overseas markets also fairly calm.
Oil prices climbed this morning, after data showed U.S. drilling slowed and a report said $1.5 trillion worth of planned production was uneconomic at current prices. (Reuters)
Remember we are in a guilty till proven innocent market and we need to be leaning towards being more nimble and fast on our feet for quick trading opportunities. Also start identifying potential entry points in stocks you want to own for swings and long term holds if the markets were to roll over.
I will be keeping a close eye on oil and the solar sectors along with the IWM SMH and TVIX. The home builders could be another sector to pay close attention to as well.
This weeks Video
http://ticker.tv/vegastrader66/55fed45472fa09f7041fa09e
Stocks on my radar premarket
Bullish and may have lottos in play
Cautiously optimistic
Very Cautious may even present a short opportunity
05:18:16am
09/21/15 |
Pluristem, NIAID Met With FDA and Agreed on Development Plan for Initiation of Pivotal Study of PLX-R18 in Treatment of ARS
|
03:56:30pm
09/20/15 |
Paratek's Omadacycline, Demonstrates Broad Spectrum Activity in Pathogens Relevant in Skin Infections, Community-acquired Pneumonia and Urinary Tract Infections
|
07:02:56am
09/21/15 |
Mitek Receives $1.4M Reorder From Global Banking and Payment Technology Provider
|
04:40:33pm
09/19/15 |
T2 Biosystems Says Study Demonstrates T2Candida Panel is More Sensitive and Rapid at Identifying Invasive Infections
|
3:39 am Matinas BioPharma presents preclinical data showing significant anti-bacterial activity against Mycobacterium avium and no noted toxicity by MAT2501 (MTNB) :
MTNB Super tiny OTC pr could get the dolla holla roll BUT Very risky trades very thin
04:39:18pm
09/19/15 |
Cidara Therapeutics Says New Data Demonstrate CD101's Potential as Potent Treatment for Serious Fungal Infections
|
07:26:33am
09/21/15 |
uniQure +15% Following Saturday Announcement of Positive Topline Results from Phase I/II Trial in Sanfilippo B Syndrome Patients Using AAV5-Based Gene Therapy
|
07:01:01am
09/21/15 |
PDL BioPharma Announces Acquisition of Portion of AcelRx Pharma, Royalties, Expected Milestones from Zalviso for $65M
|
07:01:46am
09/21/15 |
Allot Communications Receives $8M Expansion Order From a Tier-1 Operator
|
| Total Cash (mrq): | 120.64M |
| Total Cash Per Share (mrq): | 3.61 |
| Total Debt (mrq): | 0.00 |
| Shares Outstanding5: | 33.49M |
| Float: | 28.78M |
| % Held by Insiders1: | 15.57% |
| % Held by Institutions1: | 62.60% |


No comments:
Post a Comment